Chapin Davis’s Beam Therapeutics BEAM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-6,000
Closed -$206K – 260
2026
Q2
$206K Buy
+6,000
New +$181K 0.04% 244

Other funds holding BEAM

Chapin Davis's BEAM Position: Q3 2026 in Review

Chapin Davis sold out of Beam Therapeutics (BEAM) in Q3 2026, closing a stake of 6,000 shares — an estimated $206K sold.

Chapin Davis first reported a position in BEAM in Q2 2026 and held it in 1 quarter. The position peaked at $206K in Q2 2026. 191 funds tracked by Wall St. Rank hold BEAM as of Q3 2026.

  • Chapin Davis reported no remaining Beam Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Chapin Davis sold 6,000 Beam Therapeutics shares in Q3 2026, an estimated $206K.
  • Chapin Davis first reported a position in Beam Therapeutics in Q2 2026 and held it in 1 quarter.
  • Chapin Davis's Beam Therapeutics position peaked at $206K in Q2 2026.
  • 191 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2026.

Based on Chapin Davis's 13F filing for Q3 2026, filed 9 Oct 2026.